C09 – Office of HTA and Medicines Australia Update

Always a popular session, ARCS continues the tradition in having some key members from both the Department of Health and Medicines Australia come to present updates around some of the key environmental and policy developments in reimbursement.

Chairperson: Matt Slabbert, Head of Market Access, Australia & NZ at Bayer HealthCare